GENEVA, July 31 -- NANOCELL THERAPEUTICS HOLDINGS B.V. filed a patent application (IB2026/050762) for “METHODS AND COMPOSITION FOR INDUCING ACTIVATION AND DNA EXPRESSION IN T-CELLS”. With publication no. WO/2026/159700, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 40/11
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....